Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
386M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
17.3M
-
Shares change
-
-1.26M
-
Total reported value, excl. options
-
$203M
-
Value change
-
-$13.7M
-
Number of buys
-
43
-
Number of sells
-
-47
-
Price
-
$11.76
Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2015
106 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q4 2015.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.3M shares
of 386M outstanding shares and own 4.48% of the company stock.
Largest 10 shareholders include Boston Partners (1.59M shares), JANUS CAPITAL MANAGEMENT LLC (1.43M shares), Paradice Investment Management LLC (1.37M shares), HEARTLAND ADVISORS INC (1.25M shares), BANK OF MONTREAL /CAN/ (1.11M shares), ACK Asset Management LLC (1M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (754K shares), ROYCE & ASSOCIATES LLC (703K shares), Senvest Management, LLC (597K shares), and Lapides Asset Management, LLC (554K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.